pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
sozinibercept
Diabetic Macular Edema
$CKDXF
Opthea Ltd
0
catalysts
Phase 2
spevatamig
Adenocarcinoma Of The Gastroesophageal Junction
Phanes Therapeutics Inc
0
catalysts
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
0
catalysts
Phase 2
← prev
page 49 of 53
next →
131
Pain
89
Neurology
1
sunobinop tosylate
Alcohol Use Disorder (AUD)
Imbrium Therapeutics LP
0
catalysts
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
0
catalysts
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
surufatinib
Solid Tumor
Fibroblast growth factor receptor 1
Vascular endothelial growth factor receptor
$HCM
HUTCHMED (China) Ltd
0
catalysts
Phase 2
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONC
BeOne Medicines Ltd.
0
catalysts
Phase 2
sutacimig
sutacimig [INN]
Bleeding And Clotting Disorders
Hemab ApS
0
catalysts
Phase 2
suvratoxumab
Staphylococcus aureus Infections
Alpha-hemolysin
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
tagitanlimab
tagitanlimab [INN]
Nasopharyngeal Cancer
Hbm Holdings Ltd
0
catalysts
Phase 2
tagmokitug
Adenocarcinoma Of The Gastroesophageal Junction
$CHRS
Coherus Oncology, Inc.
0
catalysts
Phase 2
tagraxofusp
Elzonris (tagraxofusp-erzs)
Refractory Acute Myeloid Leukemia
Elongation factor 2
Interleukin-3 receptor subunit alpha
Stemline Therapeutics Inc
0
catalysts
Phase 2
tambiciclib
Diffuse Large B-Cell Lymphoma
$SLS
SELLAS Life Sciences Group, Inc.
0
catalysts
Phase 2
tambotatug pelitecan
Nasopharyngeal Cancer
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
tasquinimod
tasquinimod [INN]
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Active Biotech AB
0
catalysts
Phase 2
taurine
taurine [INN]
Homocystinuria
University of Colorado Denver
0
catalysts
Phase 2
tebapivat
Sickle Cell Disease
$AGIO
AGIOS PHARMACEUTICALS, INC.
0
catalysts
Phase 2
tegavivint
tegavivint [INN]
Hepatocellular Carcinoma
Iterion Therapeutics Inc
0
catalysts
Phase 2
tegoprubart
Pancreatic Islet Transplant Rejection
CD40 ligand
$ELDN
Eledon Pharmaceuticals, Inc.
0
catalysts
Phase 2
telacebec
Buruli Ulcer
Qurient Co Ltd
0
catalysts
Phase 2
telisotuzumab adizutecan
telisotuzumab adizutecan [INN]
Gastric Cancer
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
terbinafine hydrochloride
Terbinafine Hydrochloride (terbinafine hydrochloride)
Onychomycosis (Tinea Unguium)
Squalene monooxygenase
Hallux Inc
0
catalysts
Phase 2
teropavimab
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
tertomotide
tertomotide [INN]
Alzheimer's Disease
GemVax & KAEL Co Ltd
0
catalysts
Phase 2
testosterone
Testagen TDS (testosterone [INN])
Male Hypogonadism
Transdermal Delivery Solutions Corp
0
catalysts
Phase 2
testosterone tridecanoate
Sarcopenia
$LPCN
Lipocine Inc.
0
catalysts
Phase 2
theophylline
Theophylline (theophylline [USP])
Dysgeusia (Taste Disorders)
Cyrano Therapeutics Inc
0
catalysts
Phase 2
tianeptine
tianeptine [INN]
Rett Syndrome
AMO Pharma Ltd
0
catalysts
Phase 2
tibulizumab
Hidradenitis Suppurativa
Interleukin-17A
Tumor necrosis factor ligand superfamily member 13B
$ZURA
Zura Bio Ltd
0
catalysts
